We thank Prof. Smith for his comments.1 We are unaware of any published literature regarding the use of self-screened blood pressure measurements in repeat prescription requests for combined oral contraceptive pill (COCP), although we are currently undertaking some further research exploring the demographics of service users that would show if women of reproductive age are using blood pressure self-screening.
Self-screening systems are available that link a blood pressure monitor and weighing scales to a touch screen that can administer simple questionnaires such as smoking status and potentially ask about COCP side effects and use. These systems integrate the data into the patient’s electronic medical record and alert practice staff to any readings or responses that require follow-up. In theory, the annual review required for the ongoing prescription of COCP could be administered via such a system. However, whether conducting ‘pill checks’ in this manner is desirable or acceptable to women would require careful consideration.
Competing interests
Richard McManus has received BP monitoring equipment for research purposes from Omron and Lloyds Pharmacies, and has received honoraria and travel expenses from the Japanese Society of Hypertension and American Society of Nephrology.
REFERENCE
- 1.Smith C. Patient use of blood pressure self-screening facilities in general practice waiting rooms: a qualitative study in the UK. [Letter]. Br J Gen Pract. 2017 doi: 10.3399/bjgp17X690881. http://bjgp.org/content/67/660/e467/tab-e-letters#patient-use-of-blood-pressure-self-screening-in-general-practice-waiting-rooms-authors-response (accessed 6 Sep 2017) [DOI] [PMC free article] [PubMed] [Google Scholar]